Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
Ian Lyall profile image

Ian Lyall

Ian Lyall is a business journalist, investment writer and editor with a background spanning national and international news services. He specialises in pulling apart complex stories, stripping out the noise and explaining what is really going on.

238 Posts

Ian Lyall cover image
Biology’s new supply chains: Why the future of biotech may be manufacturing, not discovery post image
Evergreen Science biotech

Biology’s new supply chains: Why the future of biotech may be manufacturing, not discovery

by Ian Lyall
The end of antibiotics, again: phage therapy, bacteriocins, and precision antimicrobials post image
Evergreen Science biotech

The end of antibiotics, again: phage therapy, bacteriocins, and precision antimicrobials

by Ian Lyall
The immune system’s new teachers: Personalised cancer vaccines and the logistics of made-to-order medicine post image
Evergreen Science biotech

The immune system’s new teachers: Personalised cancer vaccines and the logistics of made-to-order medicine

by Ian Lyall
Batteries, not brains: Bioelectricity and the new map of how bodies heal post image
Evergreen Science biotech

Batteries, not brains: Bioelectricity and the new map of how bodies heal

by Ian Lyall
CRISPR’s next act: Editors that rewrite single letters without cutting the DNA post image
Evergreen Science biotech

CRISPR’s next act: Editors that rewrite single letters without cutting the DNA

by Ian Lyall
The cell’s postal service: How extracellular vesicles could become the next drug delivery revolution post image
Evergreen Science biotech

The cell’s postal service: How extracellular vesicles could become the next drug delivery revolution

by Ian Lyall
Living medicines, strange ethics: the rise of engineered microbes that treat disease from the inside post image
Evergreen Science biotech

Living medicines, strange ethics: the rise of engineered microbes that treat disease from the inside

by Ian Lyall
Organoids on a chip: Miniature human tissues that are changing how drugs are tested post image
Evergreen Science biotech

Organoids on a chip: Miniature human tissues that are changing how drugs are tested

by Ian Lyall
The quiet revolution in protein design: Enzymes and binders made by algorithms, built in yeast post image
everygreen Science biotech

The quiet revolution in protein design: Enzymes and binders made by algorithms, built in yeast

by Ian Lyall
Why robots hate doorknobs: The small piece of hardware that exposes everything robots still struggle with post image
Evergreen Tech data science

Why robots hate doorknobs: The small piece of hardware that exposes everything robots still struggle with

by Ian Lyall
Brain-computer interfaces today: Real communication breakthroughs, stubborn engineering limits, and the hype traps to avoid post image
Evergreen Science Tech

Brain-computer interfaces today: Real communication breakthroughs, stubborn engineering limits, and the hype traps to avoid

by Ian Lyall
New antibiotics explained: Phages, bacteriocins and AI, and why none is a silver bullet post image
Evergreen Science biotech

New antibiotics explained: Phages, bacteriocins and AI, and why none is a silver bullet

by Ian Lyall